Papers
1
Total Citations
11
H-Index
1
About
Dr. Yong‐An Chung is a leading researcher in the field of neuromodulation and neuropsychiatry, with a primary focus on developing advanced technologies for treating psychiatric disorders. His most notable contribution is pioneering the use of robotic transcranial magnetic stimulation (TMS) for depression, as demonstrated in his highly cited 2023 pilot study. This work addresses a critical challenge in repetitive TMS (rTMS) therapy: the need for precise, consistent coil positioning over targeted brain regions to ensure both treatment efficacy and patient safety. By integrating robotic systems into clinical protocols, Dr. Chung’s research has significantly enhanced the accuracy and reproducibility of non-invasive brain stimulation, reducing human error and improving therapeutic outcomes. His work has garnered substantial attention, with his key paper accumulating 11 citations in a short period, reflecting its immediate impact on the field. Through this innovation, Dr. Chung is bridging the gap between engineering and clinical neuroscience, offering new hope for treatment-resistant depression and setting a new standard for precision in neuromodulation. His ongoing efforts continue to shape the future of personalized, technology-driven mental health interventions.
Research Focus
Key Achievements
Top Papers
- 1